0001209191-19-004552.txt : 20190118 0001209191-19-004552.hdr.sgml : 20190118 20190118161850 ACCESSION NUMBER: 0001209191-19-004552 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190117 FILED AS OF DATE: 20190118 DATE AS OF CHANGE: 20190118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Paul M CENTRAL INDEX KEY: 0001446372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 19533423 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-17 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001446372 Silva Paul M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP & Corp Controller Common Stock 2019-01-17 4 M 0 1289 91.05 A 17376 D Common Stock 2019-01-17 4 S 0 1289 191.05 D 16087 D Common Stock 2019-01-17 4 M 0 859 90.29 A 16946 D Common Stock 2019-01-17 4 S 0 859 190.29 D 16087 D Common Stock 2019-01-17 4 M 0 859 90.29 A 16946 D Common Stock 2019-01-17 4 S 0 859 190.29 D 16087 D Common Stock 169 I 401(K) Stock Option (Right to Buy) 91.05 2019-01-17 4 M 0 1289 0.00 D 2026-02-01 Common Stock 1289 6446 D Stock Option (Right to Buy) 90.29 2019-01-17 4 M 0 859 0.00 D 2026-07-11 Common Stock 859 6016 D Stock Option (Right to Buy) 90.29 2019-01-17 4 M 0 859 0.00 D 2026-07-11 Common Stock 859 5157 D Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 02/02/2016. The option vests in 16 quarterly installments from 07/12/2016. /s/ Omar White, Attorney-in-Fact 2019-01-18